鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/08/22 | 3,065 | 3,085 | 3,050 | 3,080 | +10 | +0.3% | 23,700 |
| 2022/08/19 | 3,085 | 3,100 | 3,055 | 3,070 | +10 | +0.3% | 19,300 |
| 2022/08/18 | 3,100 | 3,105 | 3,060 | 3,060 | -55 | -1.8% | 22,600 |
| 2022/08/17 | 3,110 | 3,130 | 3,095 | 3,115 | +20 | +0.6% | 19,600 |
| 2022/08/16 | 3,085 | 3,105 | 3,065 | 3,095 | +10 | +0.3% | 17,900 |
| 2022/08/15 | 3,095 | 3,110 | 3,060 | 3,085 | -10 | -0.3% | 28,400 |
| 2022/08/12 | 3,075 | 3,130 | 3,065 | 3,095 | +45 | +1.5% | 39,700 |
| 2022/08/10 | 3,060 | 3,060 | 3,025 | 3,050 | -20 | -0.7% | 18,100 |
| 2022/08/09 | 3,085 | 3,105 | 3,050 | 3,070 | -5 | -0.2% | 31,100 |
| 2022/08/08 | 3,070 | 3,080 | 3,040 | 3,075 | -5 | -0.2% | 42,400 |
| 2022/08/05 | 3,045 | 3,085 | 3,035 | 3,080 | +82 | +2.7% | 41,800 |
| 2022/08/04 | 3,040 | 3,050 | 2,994 | 2,998 | -42 | -1.4% | 32,000 |
| 2022/08/03 | 3,110 | 3,110 | 3,035 | 3,040 | -15 | -0.5% | 39,800 |
| 2022/08/02 | 3,165 | 3,190 | 3,045 | 3,055 | -95 | -3% | 73,700 |
| 2022/08/01 | 3,230 | 3,245 | 3,140 | 3,150 | -140 | -4.3% | 99,100 |
| 2022/07/29 | 3,370 | 3,395 | 3,265 | 3,290 | -60 | -1.8% | 86,100 |
| 2022/07/28 | 3,300 | 3,350 | 3,255 | 3,350 | +85 | +2.6% | 237,400 |
| 2022/07/27 | 3,300 | 3,300 | 3,255 | 3,265 | -15 | -0.5% | 35,800 |
| 2022/07/26 | 3,295 | 3,305 | 3,280 | 3,280 | -5 | -0.2% | 32,800 |
| 2022/07/25 | 3,320 | 3,330 | 3,285 | 3,285 | -45 | -1.4% | 32,000 |
| 2022/07/22 | 3,350 | 3,360 | 3,330 | 3,330 | -35 | -1% | 25,200 |
| 2022/07/21 | 3,310 | 3,375 | 3,310 | 3,365 | -5 | -0.1% | 38,900 |
| 2022/07/20 | 3,355 | 3,385 | 3,335 | 3,370 | +70 | +2.1% | 58,900 |
| 2022/07/19 | 3,300 | 3,310 | 3,240 | 3,300 | ±0 | ±0% | 62,000 |
| 2022/07/15 | 3,370 | 3,370 | 3,290 | 3,300 | -50 | -1.5% | 40,700 |
| 2022/07/14 | 3,340 | 3,360 | 3,315 | 3,350 | -15 | -0.4% | 48,300 |
| 2022/07/13 | 3,365 | 3,395 | 3,345 | 3,365 | -45 | -1.3% | 61,600 |
| 2022/07/12 | 3,390 | 3,420 | 3,375 | 3,410 | +5 | +0.1% | 34,800 |
| 2022/07/11 | 3,330 | 3,410 | 3,330 | 3,405 | +130 | +4% | 86,500 |
| 2022/07/08 | 3,265 | 3,320 | 3,215 | 3,275 | -15 | -0.5% | 90,100 |
| 2022/07/07 | 3,305 | 3,340 | 3,280 | 3,290 | +15 | +0.5% | 64,800 |
| 2022/07/06 | 3,225 | 3,275 | 3,220 | 3,275 | +50 | +1.6% | 52,800 |
| 2022/07/05 | 3,200 | 3,225 | 3,175 | 3,225 | +25 | +0.8% | 33,100 |
| 2022/07/04 | 3,230 | 3,270 | 3,195 | 3,200 | +40 | +1.3% | 49,700 |
| 2022/07/01 | 3,230 | 3,250 | 3,150 | 3,160 | -50 | -1.6% | 57,100 |
| 2022/06/30 | 3,260 | 3,290 | 3,190 | 3,210 | -55 | -1.7% | 90,600 |
| 2022/06/29 | 3,260 | 3,265 | 3,225 | 3,265 | -40 | -1.2% | 68,700 |
| 2022/06/28 | 3,240 | 3,310 | 3,195 | 3,305 | +60 | +1.8% | 90,500 |
| 2022/06/27 | 3,220 | 3,270 | 3,205 | 3,245 | +35 | +1.1% | 78,800 |
| 2022/06/24 | 3,140 | 3,210 | 3,125 | 3,210 | +65 | +2.1% | 82,100 |
| 2022/06/23 | 3,045 | 3,160 | 3,045 | 3,145 | +145 | +4.8% | 96,200 |
| 2022/06/22 | 2,970 | 3,030 | 2,970 | 3,000 | +37 | +1.2% | 36,700 |
| 2022/06/21 | 2,945 | 2,983 | 2,931 | 2,963 | +40 | +1.4% | 51,800 |
| 2022/06/20 | 2,842 | 2,930 | 2,842 | 2,923 | +31 | +1.1% | 40,100 |
| 2022/06/17 | 2,852 | 2,912 | 2,835 | 2,892 | -22 | -0.8% | 96,200 |
| 2022/06/16 | 2,854 | 2,928 | 2,854 | 2,914 | +60 | +2.1% | 54,000 |
| 2022/06/15 | 2,894 | 2,894 | 2,854 | 2,854 | -40 | -1.4% | 32,600 |
| 2022/06/14 | 2,908 | 2,920 | 2,876 | 2,894 | -38 | -1.3% | 46,600 |
| 2022/06/13 | 2,929 | 2,949 | 2,918 | 2,932 | -12 | -0.4% | 21,400 |
| 2022/06/10 | 2,974 | 2,974 | 2,936 | 2,944 | -34 | -1.1% | 42,500 |
651～
700
件表示中 / 3682件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 445,500円 | +7.1% | -35.0% | 2.69% | 36.83倍 | 1.03倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| サンバイオ | 244,400円 | - | - | 0.00% | - | 113.20倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 東和薬品 | 253,300円 | +15.0% | -7.3% | 2.76% | 8.32倍 | 0.78倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 230,400円 | +14.2% | +41.0% | 2.00% | 11.28倍 | 1.15倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | 302,000円 | +3.0% | +27.5% | 2.65% | 19.11倍 | 0.83倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
市場注目の銘柄
チャート関連のコラム
